Edited by Alessandro Finazzi-Agr Supplementary information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made
During your consultation, our board-certified obesity medicine physician will review your medical history and determine which Medicare coverage pathway offers you the best opportunity to access GLP-1 treatment
The prevalence and phenotypic features of polycystic ovary syndrome: A systematic review and meta-analysis
Matsubara N, Mukai H, Itoh K, Nagai S
Ongoing studies are investigating the optimal combination of GLP-1 therapy with hormone replacement therapy, body composition monitoring technologies, and personalized dosing algorithms based on individual metabolic profiles
It is also important to consider the potential for rare but serious side effects of semaglutide, such as pancreatitis and changes in vision